RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Tranzyme Pharma, a late stage biopharmaceutical company engaged in the discovery and development of first-in-class small molecule therapeutics, announced today that Mark L. Peterson, PhD., Tranzyme’s Vice President of Intellectual Property and Operations Tranzyme, will present at the upcoming 2009 ACS National Meeting being held August 16-20, 2009 in Washington, DC.
